FAST vs INTS
Fastenal Company (FAST) versus Intensity Therapeutics, Inc. Common stock (INTS) — a side-by-side from cached financials, not a winner call.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
INTS does not have a complete income-statement cache yet.
FAST currently screens at market cap $49.48B and trailing P/E 43.1. INTS currently screens at market cap $7.7M.
Not investment advice. Open the FAST and INTS stock pages for the full models.
Not investment advice.